Posted On: 12/29/2014 11:28:45 PM
Post# of 30066
"Weak statistical significance" versus "highly statistically significant results." I am still jazzed about Barcode's observation today regarding the language used to describe LymPro's univariant data back in July verses the language Gerald used in the PR today regarding the new multivariant data.
Was Gerald sending shareholders an encoded message today to give us a clue of what kind of data they'll be presenting at the Conference? I think most of us missed it.
If they announce multivariant data in the 90s and tell us pharmas are already committing to use Lympro....the stock will rocket to .20 cents like it did in July, only this time without Money Runners.
Then, if our relationship with ICON becomes more concrete and they give us up front money (10 million to 40 million) the stock price will go over .30 cents on that news.
Was Gerald sending shareholders an encoded message today to give us a clue of what kind of data they'll be presenting at the Conference? I think most of us missed it.
If they announce multivariant data in the 90s and tell us pharmas are already committing to use Lympro....the stock will rocket to .20 cents like it did in July, only this time without Money Runners.
Then, if our relationship with ICON becomes more concrete and they give us up front money (10 million to 40 million) the stock price will go over .30 cents on that news.
(0)
(0)
